Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema

Detalhes bibliográficos
Autor(a) principal: Busch, Catharina
Data de Publicação: 2018
Outros Autores: Zur, Dinah, Fraser-Bell, Samantha, Laíns, Inês, Santos, Ana Rita, Lupidi, Marco, Cagini, Carlo, Gabrielle, Pierre-Henry, Couturier, Aude, Mané-Tauty, Valérie, Giancipoli, Ermete, Ricci, Giuseppe D'Amico, Cebeci, Zafer, Rodríguez-Valdés, Patricio J., Chaikitmongkol, Voraporn, Amphornphruet, Atchara, Hindi, Isaac, Agrawal, Kushal, Chhablani, Jay, Loewenstein, Anat, Iglicki, Matias, Rehak, Matus
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.22/16923
Resumo: In a real-world setting, eyes with DME considered refractory to anti-VEGF therapy after three monthly injections which were switched to DEX implant and had better visual and anatomical outcomes at 12 months than those that continued treatment with anti-VEGF therapy.
id RCAP_92778303c8bf34573427dcd30cecbaee
oai_identifier_str oai:recipp.ipp.pt:10400.22/16923
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edemaAnti-VEGF therapyDexamethasoneMacular edemaIn a real-world setting, eyes with DME considered refractory to anti-VEGF therapy after three monthly injections which were switched to DEX implant and had better visual and anatomical outcomes at 12 months than those that continued treatment with anti-VEGF therapy.SpringerRepositório Científico do Instituto Politécnico do PortoBusch, CatharinaZur, DinahFraser-Bell, SamanthaLaíns, InêsSantos, Ana RitaLupidi, MarcoCagini, CarloGabrielle, Pierre-HenryCouturier, AudeMané-Tauty, ValérieGiancipoli, ErmeteRicci, Giuseppe D'AmicoCebeci, ZaferRodríguez-Valdés, Patricio J.Chaikitmongkol, VorapornAmphornphruet, AtcharaHindi, IsaacAgrawal, KushalChhablani, JayLoewenstein, AnatIglicki, MatiasRehak, Matus2021-02-08T16:09:38Z2018-052018-05-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.22/16923engBusch, C., Zur, D., Fraser-Bell, S. et al. Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema. Acta Diabetol 55, 789–796 (2018). https://doi.org/10.1007/s00592-018-1151-x10.1007/s00592-018-1151-xmetadata only accessinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-13T13:05:12Zoai:recipp.ipp.pt:10400.22/16923Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:36:33.932843Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
title Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
spellingShingle Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
Busch, Catharina
Anti-VEGF therapy
Dexamethasone
Macular edema
title_short Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
title_full Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
title_fullStr Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
title_full_unstemmed Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
title_sort Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
author Busch, Catharina
author_facet Busch, Catharina
Zur, Dinah
Fraser-Bell, Samantha
Laíns, Inês
Santos, Ana Rita
Lupidi, Marco
Cagini, Carlo
Gabrielle, Pierre-Henry
Couturier, Aude
Mané-Tauty, Valérie
Giancipoli, Ermete
Ricci, Giuseppe D'Amico
Cebeci, Zafer
Rodríguez-Valdés, Patricio J.
Chaikitmongkol, Voraporn
Amphornphruet, Atchara
Hindi, Isaac
Agrawal, Kushal
Chhablani, Jay
Loewenstein, Anat
Iglicki, Matias
Rehak, Matus
author_role author
author2 Zur, Dinah
Fraser-Bell, Samantha
Laíns, Inês
Santos, Ana Rita
Lupidi, Marco
Cagini, Carlo
Gabrielle, Pierre-Henry
Couturier, Aude
Mané-Tauty, Valérie
Giancipoli, Ermete
Ricci, Giuseppe D'Amico
Cebeci, Zafer
Rodríguez-Valdés, Patricio J.
Chaikitmongkol, Voraporn
Amphornphruet, Atchara
Hindi, Isaac
Agrawal, Kushal
Chhablani, Jay
Loewenstein, Anat
Iglicki, Matias
Rehak, Matus
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Politécnico do Porto
dc.contributor.author.fl_str_mv Busch, Catharina
Zur, Dinah
Fraser-Bell, Samantha
Laíns, Inês
Santos, Ana Rita
Lupidi, Marco
Cagini, Carlo
Gabrielle, Pierre-Henry
Couturier, Aude
Mané-Tauty, Valérie
Giancipoli, Ermete
Ricci, Giuseppe D'Amico
Cebeci, Zafer
Rodríguez-Valdés, Patricio J.
Chaikitmongkol, Voraporn
Amphornphruet, Atchara
Hindi, Isaac
Agrawal, Kushal
Chhablani, Jay
Loewenstein, Anat
Iglicki, Matias
Rehak, Matus
dc.subject.por.fl_str_mv Anti-VEGF therapy
Dexamethasone
Macular edema
topic Anti-VEGF therapy
Dexamethasone
Macular edema
description In a real-world setting, eyes with DME considered refractory to anti-VEGF therapy after three monthly injections which were switched to DEX implant and had better visual and anatomical outcomes at 12 months than those that continued treatment with anti-VEGF therapy.
publishDate 2018
dc.date.none.fl_str_mv 2018-05
2018-05-01T00:00:00Z
2021-02-08T16:09:38Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.22/16923
url http://hdl.handle.net/10400.22/16923
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Busch, C., Zur, D., Fraser-Bell, S. et al. Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema. Acta Diabetol 55, 789–796 (2018). https://doi.org/10.1007/s00592-018-1151-x
10.1007/s00592-018-1151-x
dc.rights.driver.fl_str_mv metadata only access
info:eu-repo/semantics/openAccess
rights_invalid_str_mv metadata only access
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Springer
publisher.none.fl_str_mv Springer
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131456618889216

Registros relacionados